Rapport Therapeutics Inc (RAPP)
R&D Expense Growth
57.15%
Quarterly · Period ending:
RAPP R&D Expense Growth
Latest reported57.15%period ending
Latest reported57.15%period ending
RAPP Quarterly R&D Growth (QoQ) (0.00% → 57.15%)
Latest values, visible window
High-resolution chart · PNG
RAPP r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 57.1525% | |
| 8.1235% | |
| 35.814% | |
| -1.7681% | |
| 15.8798% | |
| 13.7973% | |
| 10.6543% | |
| -0.9306% | |
| 25.4718% | |
| 5.9751% | |
| 55.6596% | |
| 60.5592% | |
| 21.0823% | |
| 0% |